Login
No login? Register now to unlock hella tokens
No login? Register now to unlock hella tokens
Log In person
Iovance Biotherapeutics Inc logo
Iovance Biotherapeutics Inc IOVA
summarize 1 total product line
calendar_month Revenue as of 12/31/2023
Reporting Segmentarrow_drop_up Product Line Amount (USD) Percentage
keyboard_arrow_right Reporting Segment & Product Line Amount (USD) Percentage
Pre-Rev Biotech
Pre-Revenue Gene Editing Pharmaceuticals
These companies research and develop pharmaceuticals related to gene editing, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.
1.19M 100.00%
keyboard_arrow_right keyboard_arrow_down
Pre-Rev Biotech
Pre-Revenue Gene Editing Pharmaceuticals
1.19M 100.00%
keyboard_arrow_right
These companies research and develop pharmaceuticals related to gene editing, but do not generate significant revenue. They may eventually market or manufacture their products (pending regulatory approval) or generate revenue through royalties or other means.